Search results
The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
Zacks via Yahoo Finance Canada· 3 weeks agoFor Immediate Releases Chicago, IL – July 8, 2024 – Zacks.com announces the list of stocks featured...
FDA Approves Second Alzheimer’s Drug after Trial Shows it Can Slow Disease by 35%
The Daily Beast via Yahoo Canada News· 3 weeks agoThe Federal Drug Administration gave the go-ahead to a second Alzheimer’s treatment Tuesday after a...
Is Eli Lilly (LLY) a Buy on Tirzepatide Success in Sleep Apnea?
Zacks via Yahoo Finance Canada· 1 month agoEli Lilly (LLY) files for the approval of tirzepatide to treat obstructive sleep apnea in adults...
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab (Revised)
Zacks via Yahoo Finance Canada· 1 month agoIf Eli Lilly's (LLY) donanemab is approved by the FDA, it will become the second drug approved by...
Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
Zacks via Yahoo Finance Canada· 2 months agoBiogen BIIB announced that the European Commission (EC) has granted marketing approval to Qalsody...
Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline
Zacks via Yahoo Finance Canada· 2 months agoBiogen BIIB entered into a definitive agreement to acquire private biotech, HI-Bio, for a $1.15...
Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
Zacks via Yahoo Finance Canada· 2 months agoBiogen (BIIB) and Eisai start the rolling submission of a biologics license application to the FDA...
Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
Zacks via Yahoo Finance Canada· 3 months agoSage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales...
CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug
Zacks via Yahoo Finance Canada· 4 months agoPer Biogen (BIIB)/Eisai, the delay in CHMP recommendation for lecanemab is entirely related to...
Lilly (LLY) Stock Down as FDA Delays Decision on Donanemab
Zacks via Yahoo Finance Canada· 5 months agoEli Lilly and Company’s LLY stock declined 2.3% on Friday after it announced that an FDA decision on...